NCT02812979View on ClinicalTrials.gov

Evaluation of the Effectiveness of the Nebulization Bronchodilators Under High Nasal Flow Humidified

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

April 27, 2018

Study Completion Date

April 27, 2018

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DEVICE

Airvo2 with Aerogen Solo

Nebulization of salbutamol with Airvo 2 and Aerogen solo

DEVICE

Mask

Usual nebulization of salbutamol with mask

DEVICE

arm control Airvo2 without nebulization of salbutamol

Airvo2 with Aerogen Solo. No nebulization of salbutamol

Trial Locations (1)

37044

Service de Réanimation Polyvalente, Tours

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT02812979 - Evaluation of the Effectiveness of the Nebulization Bronchodilators Under High Nasal Flow Humidified | Biotech Hunter | Biotech Hunter